A group of 38 hospitals sued HHS over a new rule that cuts Medicare payments for some services provided at off-campus hospital sites.
The Medicaid and CHIP Payment and Access Commission is slated to meet to review recommendations on disproportionate-share hospital allotments, upper payment limit compliance, measuring program integrity and more.
The CMS' proposed rule governing Affordable Care Act exchange payments in 2020 included cutting user fees and laying the groundwork to eliminate "silver-loading."
The Food and Drug Administration is preparing to allow the over-the-counter purchase of the drug overdose-reversal medication naloxone in an effort to expand greater access to the lifesaving drug.
Regulations.gov, the website used to view and submit comments on federal regulations and rules, will be shut down for at least 24 hours due to technical difficulties. The site's landing page said it was closing due to the government shutdown.
Providers, vendors and others told the Government Accountability Office they still struggle with correctly matching patients to their records, which can theoretically put patients in danger.
A federal appeals court unanimously ruled against UnitedHealth Group over the insurer withholding payments from out-of-network physicians and hospitals to compensate for previous overpayments.
Two Supreme Court justices questioned the federal government's assertion that its Medicare DSH formula change didn't amount to substantive policy. The change affects billions of dollars in reimbursement payments.
HHS Secretary Alex Azar said a proposal to tie prices for certain Medicare drugs to lower prices paid overseas is already paying dividends even though it hasn't formally been introduced yet.
HHS and hospitals will argue before the U.S. Supreme Court this week over whether HHS violated the law when it recalculated the Medicare DSH payment formula without seeking public comment.
A federal judge in California blocked Trump administration rules, which would allow more employers to opt out of providing women with no-cost birth control, from taking effect in 13 states and Washington, D.C.
The Trump administration continues its verbal assault on high drug prices, and more-concrete regulatory action is expected this year.